Persistent Asset Partners LTD Pure Tech Health PLC Call Options Transaction History
Persistent Asset Partners LTD
- $135 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PRTC
# of Institutions
7Shares Held
111KCall Options Held
0Put Options Held
0-
Pentwater Capital Management LP Naples, FL50KShares$855,0000.01% of portfolio
-
Portolan Capital Management, LLC Boston, MA27.8KShares$475,2940.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny23.9KShares$407,9540.0% of portfolio
-
Diadema Partners LP Morristown, NJ7.32KShares$125,2400.04% of portfolio
-
Ubs Group Ag20Shares$3420.0% of portfolio
About PureTech Health plc
- Ticker PRTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,888,500
- Market Cap $477M
- Description
- PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholi...